Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Besse

Showing results (31-40 of 511) with videos related to

Pageof 52
Sort By:
The European Respiratory Journal|May 2, 2015
Therapeutic management of ALK+ nonsmall cell lung cancer patientsBoris Duchemann, Luc Friboulet, Benjamin Besse
Cancers|July 24, 2021
Comment on Hopkins et al. Value of the Lung Immune Prognostic Index in Patients with Non-Small Cell Lung Cancer Initiating First-Line Atezolizumab Combination Therapy: Subgroup Analysis of the IMPOWER150 Trial. <i>Cancers</i> 2021, <i>13</i>, 1176Edouard Auclin, Laura Mezquita, Benjamin Besse
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 2025
Metabolic Tumor Volume and Immunotherapy in NSCLC-ReplyFilippo Dall'Olio, Benjamin Besse, Camilo Garcia
Chinese Clinical Oncology|January 6, 2016
Methodology of clinical trials in lung cancerJessica Menis, Benjamin Besse, Denis Lacombe
Cancer Cell|January 18, 2020
One or Two Immune Checkpoint Inhibitors?Caroline Robert, Emilie Lanoy, Benjamin Besse
Lancet (London, England)|December 11, 2023
The need for pragmatic, affordable, and practice-changing real-life clinical trials in oncologyAlexandra Leary, Benjamin Besse, Fabrice André
The Lancet. Respiratory Medicine|April 20, 2019
Exploring the optimal use of alectinibDiego Enrico, Christophe Massard, Benjamin Besse
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 26, 2019
Letter to the Editor about Sorich et alLaura Mezquita, Edouard Auclin, Benjamin Besse
JAMA Oncology|March 22, 2019
Hyperprogression-Immunotherapy-Related Phenomenon vs Intrinsic Natural History of Cancer-In ReplyRoberto Ferrara, Caroline Caramella, Benjamin Besse
Presse Medicale (Paris, France : 1983)|March 23, 2011
[Lung cancer in never smoker: Epidemiology, molecular profiles and treatment]Julien Hadoux, Benjamin Besse, David Planchard
Pageof 52

Showing results (31-40 of 511) with videos related to

Sort By:
Pageof 52
The European Respiratory Journal|May 2, 2015
Therapeutic management of ALK+ nonsmall cell lung cancer patientsBoris Duchemann, Luc Friboulet, Benjamin Besse
Cancers|July 24, 2021
Comment on Hopkins et al. Value of the Lung Immune Prognostic Index in Patients with Non-Small Cell Lung Cancer Initiating First-Line Atezolizumab Combination Therapy: Subgroup Analysis of the IMPOWER150 Trial. <i>Cancers</i> 2021, <i>13</i>, 1176Edouard Auclin, Laura Mezquita, Benjamin Besse
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 2025
Metabolic Tumor Volume and Immunotherapy in NSCLC-ReplyFilippo Dall'Olio, Benjamin Besse, Camilo Garcia
Chinese Clinical Oncology|January 6, 2016
Methodology of clinical trials in lung cancerJessica Menis, Benjamin Besse, Denis Lacombe
Cancer Cell|January 18, 2020
One or Two Immune Checkpoint Inhibitors?Caroline Robert, Emilie Lanoy, Benjamin Besse
Lancet (London, England)|December 11, 2023
The need for pragmatic, affordable, and practice-changing real-life clinical trials in oncologyAlexandra Leary, Benjamin Besse, Fabrice André
The Lancet. Respiratory Medicine|April 20, 2019
Exploring the optimal use of alectinibDiego Enrico, Christophe Massard, Benjamin Besse
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 26, 2019
Letter to the Editor about Sorich et alLaura Mezquita, Edouard Auclin, Benjamin Besse
JAMA Oncology|March 22, 2019
Hyperprogression-Immunotherapy-Related Phenomenon vs Intrinsic Natural History of Cancer-In ReplyRoberto Ferrara, Caroline Caramella, Benjamin Besse
Presse Medicale (Paris, France : 1983)|March 23, 2011
[Lung cancer in never smoker: Epidemiology, molecular profiles and treatment]Julien Hadoux, Benjamin Besse, David Planchard
Pageof 52